LXEO
Lexeo Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.76
+4.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-37.1%
Return on equity
-34.2%
Return on assets
-39.3%
Return on invested capital
0.00x
Asset turnover
-$88.4M
Cash from operations
$2.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026